Does SINTILIMAB Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with SINTILIMAB. This represents 0.9% of all adverse event reports for SINTILIMAB.
6
Reports of Malignant neoplasm progression with SINTILIMAB
0.9%
of all SINTILIMAB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SINTILIMAB?
Of the 6 reports, 2 (33.3%) resulted in death, 4 (66.7%) required hospitalization, and 3 (50.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SINTILIMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does SINTILIMAB Cause?
Myelosuppression (127)
Nausea (77)
Rash (72)
Vomiting (68)
Off label use (64)
Hypothyroidism (62)
Diarrhoea (61)
Fatigue (60)
Anaemia (59)
Pyrexia (51)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SINTILIMAB Alternatives Have Lower Malignant neoplasm progression Risk?
SINTILIMAB vs SIPONIMOD
SINTILIMAB vs SIPULEUCEL-T
SINTILIMAB vs SIROLIMUS
SINTILIMAB vs SIRUKUMAB
SINTILIMAB vs SITAGLIPTIN